Arrowhead Pharmaceuticals (ARWR) - NASDAQ
  • william | Send Message 12 Jul

    $ARWR a little stale but a great verbal on ARWR-Strong Buy pub in biz since 1984
    Reply (1)
    • IndyPEG | Send Message 12 Jul
      : Can't wait to get back long the name of it breaks 6.50
      • Alexander Valtsev | Send Message 14 Jun

        One ​Biotech Stock Whose Fortune May Reverse, One to Avoid: $ARWR
          • Slingshot Insights | Send Message 19 Apr

            This Week In Pharma: Can Radius' Abaloparatide-SC Beat Current Osteoporosis Drugs? Will Arrowhead... $ARWR
              • timtrading | Send Message 14 Apr
                  • freefdawatchlist | Send Message 8 Feb

           Earnings after Hour: $DIS, $SCTY, $AKAM, $RKUS, $NUAN, $ARWR, $DWRE, $USNA, $WU, $CALX
                      • BayesianLearner | Send Message 13 Jan

                        Unlocking Deep Value With Arrowhead Research $ARWR
                          • WItrader18 | Send Message 7 Jan

                            $ARWR at $5.05
                            Reply (2)
                            • matratra | Send Message 7 Jan
                              : good trade
                            • WItrader18 | Send Message 14 Apr
                              : Sold $5.98 $ARWR
                              • Kanak Kanti De | Send Message 28 Dec 2015

                                Premarket Biotech Digest: Arrowhead's Potential, KaloBios Delisting, BiondVax Patent $ARWR
                                  • pat45 | Send Message 14 Dec 2015

                                    $ARWR will be added to index December 21. That should give some big buys of stock.
                                      • Kanak Kanti De's Real-Time Biotech Trade Alerts | Send Message 25 Nov 2015

                                        Arrowhead Research: Some Questions For Management $ARWR
                                          Company Description
                                          Arrowhead Research Corp. is a biopharmaceutical company developing targeted RNAi therapeutics. It is leveraging its proprietary drug delivery technologies to develop drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Its pipeline includes clinical... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States